Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients
Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients
| Reumatismo
© PAGEPress 2008-2023 • PAGEPress® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy
Comments (0)